-+ 0.00%
-+ 0.00%
-+ 0.00%

SILO PHARMA: JOINT VENTURE TO DEVELOP FIRST-IN-CLASS GDNF-BASED THERAPY LICENSED FROM U.S. DEPT OF VETERANS AFFAIRS

Reuters·06/25/2025 12:28:21

Please log in to view news